Cargando…

Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout Study

OBJECTIVE: To estimate the prevalence and distribution of asymptomatic monosodium urate monohydrate (MSU) crystal deposition in sons of patients with gout. METHODS: Patients with gout were mailed an explanatory letter with an enclosed postage‐paid study packet to mail to their son(s) age ≥20 years o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abhishek, Abhishek, Courtney, Philip, Jenkins, Wendy, Sandoval‐Plata, Gabriela, Jones, Adrian C., Zhang, Weiya, Doherty, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Gout
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220843/ https://www.ncbi.nlm.nih.gov/pubmed/29806203 http://dx.doi.org/10.1002/art.40572

Ejemplares similares

Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial
por: Saag, Kenneth G., et al.
Publicado: (2022)

Development and First Validation of a Disease Activity Score for Gout
por: Scirè, Carlo A., et al.
Publicado: (2016)

Computational Lexical Analysis of the Language Commonly Used to Describe Gout
por: Lawrence Edwards, N., et al.
Publicado: (2016)

Effects of Febuxostat in Early Gout: A Randomized, Double‐Blind, Placebo‐Controlled Study
por: Dalbeth, Nicola, et al.
Publicado: (2017)

A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout
por: Poiley, Jeffrey, et al.
Publicado: (2016)

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo‐Controlled Study
por: Saag, Kenneth G., et al.
Publicado: (2018)

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial
por: Dalbeth, Nicola, et al.
Publicado: (2017)

A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings
por: Botson, John K., et al.
Publicado: (2022)

Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion
por: Yan, Fei, et al.
Publicado: (2022)

A novel role for monosodium urate monohydrate crystals and gouty synovial fluids in monocyte migration in gout
por: Amin, M Asif, et al.
Publicado: (2012)

Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol
por: Dalbeth, Nicola, et al.
Publicado: (2018)

Urate in fingernail represents the deposition of urate burden in gout patients
por: Chen, Haibing, et al.
Publicado: (2020)

Are polymorphisms affecting serum urate, renal urate handling and alcohol intake associated with co-morbidities in gout cases? A case–control study using data from the UK Biobank
por: Sandoval-Plata, Gabriela, et al.
Publicado: (2022)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

Detection of intracellular monosodium urate crystals in gout synovial fluid using optical diffraction tomography
por: Park, Sangwoo, et al.
Publicado: (2021)

Evaluation of the anti-gout effect of Sonchus Arvensis on monosodium urate crystal-induced gout arthritis via anti-inflammatory action - an in vivo study
por: Parisa, Nita, et al.
Publicado: (2021)

Association of Specific Comorbidities with Monosodium Urate Crystal Deposition in Urate-Lowering Therapy-Naive Gout Patients: A Cross-Sectional Dual-Energy Computed Tomography Study
por: Pascart, Tristan, et al.
Publicado: (2020)

Urate-lowering treatment and risk of total joint replacement in patients with gout
por: Kuo, Chang-Fu, et al.
Publicado: (2018)

Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout
por: Ahn, Huijeong, et al.
Publicado: (2021)

Downregulation of Sox8 mediates monosodium urate crystal-induced autophagic impairment of cartilage in gout arthritis
por: Xiao, Lu, et al.
Publicado: (2023)

Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial
por: Doherty, Michael, et al.
Publicado: (2018)

Burden and distribution of monosodium urate deposition in patients with hyperuricemia and gout: a cross-sectional Chinese population-based dual-energy CT study
por: Zhang, Xin-Yu, et al.
Publicado: (2023)

Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis?
por: Orlowsky, Eric W, et al.
Publicado: (2014)

Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout
por: Liu, Lei, et al.
Publicado: (2016)

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment
por: Abhishek, Abhishek, et al.
Publicado: (2022)

A Detailed Analysis of the Association between Urate Deposition and Erosions and Osteophytes in Gout
por: Pecherstorfer, Caroline, et al.
Publicado: (2020)

Dual-energy CT in gout patients: Do all colour-coded lesions actually represent monosodium urate crystals?
por: Christiansen, Sara Nysom, et al.
Publicado: (2020)

Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study
por: Cipolletta, Edoardo, et al.
Publicado: (2021)

Testing Topical Products Specifically to Reduce Inflammatory Pain from Gout: Transdermal NSAID Delivery and Monosodium Urate Solubility
por: Hooper, Mark W, et al.
Publicado: (2022)

Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study: MSU burden and risk of gout flare
por: Pascart, Tristan, et al.
Publicado: (2018)

Upregulated expression of FFAR2 and SOC3 genes is associated with gout
por: Orji, Oliver C, et al.
Publicado: (2022)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

Role of Dual-Energy Computed Tomography in the Identification of Monosodium Urate Deposition in Gout Patients: A Comprehensive Analysis of 828 Joints According to Structural Joint Damage
por: Nhi, Le Huu Hanh, et al.
Publicado: (2021)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Gout. Epidemiology of gout
por: Roddy, Edward, et al.
Publicado: (2010)

Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study
por: Hammer, Hilde Berner, et al.
Publicado: (2022)

Son o no son /
por: Gutiérrez Silva, José Alfredo
Publicado: (2017)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r84emb4hkci68s7vjm7rl6oh0h